Prostate cancer screening and bacteraemia

Medical Journal of Australia

Volumn 188, Issue 1, 2008, Pages 60-

  Bowden, Francis J ^a   Roberts, Jan ^b   Collignon, Peter J ^b  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^b CANBERRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

BLOOD CULTURE; CANCER SCREENING; GRAM NEGATIVE SEPSIS; HOSPITAL ADMISSION; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; LETTER; PROSTATE BIOPSY; PROSTATE CANCER; PUBLIC HOSPITAL; TRANSRECTAL ULTRASONOGRAPHY; AUSTRALIA; BACTEREMIA; BIOPSY; ENDOSCOPIC ECHOGRAPHY; MALE; MASS SCREENING; METHODOLOGY; PATHOLOGY; PROSTATE; PROSTATE TUMOR;

AUSTRALIA; BACTEREMIA; BIOPSY; HUMANS; MALE; MASS SCREENING; PROSTATE; PROSTATIC NEOPLASMS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 42149174379     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2008.tb01513.x     Document Type: Letter

References (5)

1. Ilic D, O'Connor D, Green S, Wilt T. Screening for prostate cancer. Cochrane Database Syst Rev 2006; (3): CD004720.
2. Djavan B, Waldert M, Zlotta A, et al. Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study. J Urol 2001; 166: 856-860.
3. Peralta G, Sanchez MB, Garrido JC, et al. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia. J Antimicrob Chemother 2007; 60: 855-863.
4. Medicare Australia. Medicare Benefits Schedule (MBS) item statistics reports. http://www.medicareaustralia.gov.au/statistics/dyn_mbs/forms/ mbs_tab4ag.shtml (accessed Oct 2007).
5. Frankel S, Smith GD, Donovan J, et al. Screening for prostate cancer. Lancet 2003; 361: 1122-1128.